VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation

Nature Medicine

Volumn 5, Issue 6, 1999, Pages 623-628

  Gerber, Hans Peter ^a   Vu, Thienne H ^b   Ryan, Anne M ^a   Kowalski, Joe ^a   Werb, Zena ^b   Ferrara, Napoleone ^a  

^a GENENTECH INC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BONE GROWTH; CARTILAGE CELL; CELL DEATH; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; ENCHONDRAL OSSIFICATION; EXTRACELLULAR MATRIX; GROWTH PLATE; HUMAN CELL; HYPERTROPHY; MOUSE; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD31; BONE AND BONES; CARTILAGE; CELL DIVISION; CHONDROCYTES; ENDOTHELIAL GROWTH FACTORS; IMMUNOGLOBULIN G; LYMPHOKINES; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOGENESIS; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RECOMBINANT PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033027858     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/9467     Document Type: Article

References (44)

1. Poole, A.R. in Cartilage: Molecular Aspects (eds. Hall, B.K. & Newman, S.A.) 179-211 (CRC Press, Boca Raton, Florida, 1991).
2. Jee, W.S.S. in Cell and Tissue Biology (ed. Weiss, L.) 213-253 (Urban & Schwarzemberg, New York, 1988).
3. Baron J. et al. Induction of growth plate cartilage ossification by basic fibroblast growth factor. Endocrinology 135, 2790-2793 (1994).
4. Babic A.M., Kireeva M.L., Kolesnikova T.V., & Lau L.F. CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc. Natl. Acad. Sci. USA 95, 6355-6360 (1998).
5. Shinar, D.M., Endo, N., Halperin, D., Rodan, G.A, & Weinreb, M. Differential expression of insulin-like growth factor-I (IGF-I) and IGF-II messenger ribonucleic acid in growing rat bone. Endocrinology 132, 1158-1167 (1993).
6. Jingushi, S, Scully, S.P., Joyce, M.E., Sugioka, Y., & Bolander, M.E. Transforming growth factor-beta 1 and fibroblast growth factors in rat growth plate. J. Orthop. Res. 13, 761-768 (1995).
7. Carlevaro, M.F. et al. Transferrin promotes endothelial cell migration and invasion: implication in cartilage neovascularization J. Cell Biol. 136, 1375-1384 (1997).
8. Ferrara, N. & Davis-Smyth, T. The biology of vascular endothelial growth factor. Endocr. Rev. 18, 4-25 (1997).
9. Fong, G. H., Rossant, J., Gertsenstein, M., & Breitman, M. L. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376, 66-70 (1995).
10. Shalaby, F. et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62-66 (1995).
11. Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M. & Heldin, C.-H. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor J. Biol. Chem. 268, 26988-26995 (1994).
12. Keyt, B.A. et al. Identification of VEGF determinants for binding Flt-1 and KDR receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis. J. Biol. Chem. 271, 5638-5646 (1996).
13. Gerber, H.P. et al. VEGF regulates endothelial cell survival by the PI3-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J. Biol. Chem. 273, 30336-30345 (1998).
14. Hiratsuka, S., Minowa, O., Kuno, J., Noda, T., and Shibuya, M. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc. Natl. Acad. Sci. USA 95, 9349-9354 (1998).
15. Barleon, B. et al. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87 3336-3343 (1996).
16. Soker, S., Takashima, S., Miao, H. Q., Neufeld, G., & Klagsbrun, M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92 735-745 (1998).
17. Ferrara, N. et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442 (1996).
18. Carmeliet, P. et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439 (1996).
19. Gerber, H. P. et al. VEGF is required for growth and survival in neonatal mice. Development. 126, 1149-1159 (1999).
20. Ferrara, N. et al. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nature Med. 4, 336-340 (1998).
21. Davis-Smyth, T., Chen, H., Park, J., Presta, L.G., & Ferrara, N. The second immunoglobulin-like domain of the VEGF tyrosine kinase receptot Flt-1 determines ligand binding and may initiate a signal transduction cascade. EMBO J. 15, 4919-4927 (1996).
22. Ala-Kokko, L., & Prockop, D. J. Completion of the intron-exon structure of the gene for human type II procollagen (COL2A1): variations in the nucleotide sequences of the alleles from three chromosomes. Genomics 8, 454-460 (1990).
23. Elima, K. et al. The mouse collagen X gene: complete nucleotide sequence, exon structure and expression pattern. Biochem. J. 289, 247-253 (1993).
24. Farnum, C.E. & Wilsman, N.J. Condensation of hypertrophic chondrocytes at the chondro-osseous junction of growth plate cartilage in Yucatan swine: relationship to long bone growth. Am. J. Anot. 186, 346-358 (1989).
25. Lewinson, D., & Silberman, M. Chondroclasts and endothelial cells collaborate in the process of cartilage resorption. Anat. Rec. 233, 504-514 (1992).
26. Vu, T.H. et al. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93, 411-422 (1998).
27. Shen, B.Q. et al. Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro. J. Biol. Chem. 273, 29979-29985 (1998).
28. Barleon, B. et al. Vascular endothelial growth factor up-regulates its receptor fms- like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells. Cancer Res. 57, 5421-5425 (1997).
29. Alon, T. et al. Vascular endothelial growth factor acts a s survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nature Med. 1, 1024-1028 (1995).
30. Yuan, F. et al. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by anti-VEGF/VPF antibody Proc. Nat. Acad. Sci. USA 93, 14765-14770 (1996).
31. Simionescu, N. & Simionescu, M. in Endothelial Cell Dysfunctions (Plenum, New York, 1992).
32. Midy, V. & Plouet, J. Vasculotropin/vascular endothelial growth factor induces differentiation in cultured osteoblasts. Biochem. Biophys. Res. Commun. 199 380-386 (1994).
33. Carmeliet, P., & Collen, D. Vascular development and disorders: molecular analysis and pathogenic insights. Kidney Internat. 53, 1519-1549 (1998).
34. Enholm, B., Jussila, L., Karkkainen, M., & Alitalo, K. Vascular endothelial growth factor-C: A growth factor for lymphatic and blood vessel endothelial cells. Trends Cardiovasc. Med. 8, 292-296 (1998).
35. Ryan, A.M. et al. Preclinical safety evaluation of rhuMAbVEGF, an antiangiogenic humanized monoclonal antibody. Toxicol. Pathol. 27, 78-86 (1999).
36. Barness, L.A. in Potter's Pathology of the Fetus and Infant (ed. Gilbert-Barness, E.) 561-563 (Mosby, St. Louis, Missouri, 1997).
37. Schlaeppi, J.M., Gutzwiller, S., Finkenzeller, G., & Fournier, B. 1,25-Dihydroxyvitamin D3 induces the expression of vascular endothelial growth factor in osteoblastic cells. Endocr. Res. 23, 213-229 (1997).
38. Maroteaux, P. et al. Opsismodysplasia: a new type of chondrodysplasia with predominant involvement of the bones of the hand and the vertebrae. Am. J. Med. Genet. 19, 171-182 (1984).
39. Shehan, D.C. & Hrapchak, B.B. in Theory and Practice of Histotechnology (Lipshaw, 1980).
40. Albrecht, U., Eichele, G., Helms, J. A., & Lu, H. in Molecular and Cellular Methods in Developmental Toxicology (ed. Daston, G.P.) 23-48 (CRC Press, Boca Raton, Florida, 1997).
41. Metsaranta, M., Toman, D., De Crombrugghe, B., & Vuorio, E. Specific hybridization probes for mouse type I, II, III and IX collagen mRNAs. Biochim. Biophys. Acta 1089, 241-243 (1991).
42. Reponen, P., Sahlberg, C., Munaut, C., Thesleff, I., & Tryggvason, K. High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development. J. Cell Biol. 124, 1091-1102 (1994).
43. Finnerty, H. et al. Molecular cloning of murine FLT and FLT4. Oncogens 8, 2293-2298 (1993).
44. Quinn, T.P., Peters, K.G., deVries, C., Ferrara, N. & Williams, L.T. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc. Natl. Acad. Sci. USA 90, 7533-7537 (1993).